JIP
ARKG icon

Jaffetilchin Investment Partners’s ARK Genomic Revolution ETF ARKG Stock Holding History

Jaffetilchin Investment Partners’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$262K Sell
9,921
-3,433
-26% -$101K 0.02% 394
2025
Q4 		$387K Sell
13,354
-28,911
-68% -$868K 0.02% 309
2025
Q3 		$1.17M Buy
42,265
+1,443
+4% +$36.5K 0.07% 172
2025
Q2 		$994K Buy
+40,822
New +$895K 0.07% 183
2024
Q4 		– Sell
-1,427
Closed -$36.5K – 429
2024
Q3 		$36.5K Buy
+1,427
New +$36.3K ﹤0.01% 632
2023
Q2 		– Sell
-12,916
Closed -$388K – 359
2023
Q1 		$388K Sell
12,916
-505
-4% -$15.6K 0.04% 244
2022
Q4 		$379K Sell
13,421
-1,056
-7% -$33.5K 0.05% 233
2022
Q3 		$476K Sell
14,477
-516
-3% -$18.9K 0.06% 182
2022
Q2 		$472K Sell
14,993
-598
-4% -$20.9K 0.06% 190
2022
Q1 		$460K Sell
15,591
-17,031
-52% -$812K 0.05% 196
2021
Q4 		$2M Sell
32,622
-19,273
-37% -$1.33M 0.19% 84
2021
Q3 		$3.88M Buy
51,895
+2,605
+5% +$219K 0.41% 46
2021
Q2 		$4.56M Buy
49,290
+4,740
+11% +$403K 0.31% 58
2021
Q1 		$3.95M Buy
44,550
+13,102
+42% +$1.3M 0.47% 44
2020
Q4 		$2.93M Sell
31,448
-4,339
-12% -$346K 0.42% 36
2020
Q3 		$2.28M Sell
35,787
-7,940
-18% -$465K 0.42% 40
2020
Q2 		$2.28M Buy
43,727
+24,831
+131% +$1.07M 0.5% 35
2020
Q1 		$591K Buy
+18,896
New +$631K 0.21% 72

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Jaffetilchin Investment Partners's ARKG Position: Q1 2026 in Review

Jaffetilchin Investment Partners reduced its ARK Genomic Revolution ETF (ARKG) stake by 26% in Q1 2026, selling an estimated $101K and leaving 9,921 shares worth $262K. The position accounts for 0.02% of the portfolio, ranked #394.

Jaffetilchin Investment Partners first reported a position in ARKG in Q1 2020 and has held it in 18 quarters since. The position peaked at $4.56M in Q2 2021. 218 funds tracked by Wall St. Rank hold ARKG as of Q1 2026.

  • Jaffetilchin Investment Partners held 9,921 shares of ARK Genomic Revolution ETF worth $262K as of Q1 2026.
  • Jaffetilchin Investment Partners sold 3,433 ARK Genomic Revolution ETF shares in Q1 2026, an estimated $101K.
  • ARK Genomic Revolution ETF made up 0.02% of Jaffetilchin Investment Partners's portfolio in Q1 2026, its #394 holding.
  • Jaffetilchin Investment Partners first reported a position in ARK Genomic Revolution ETF in Q1 2020 and has held it in 18 quarters since.
  • Jaffetilchin Investment Partners's ARK Genomic Revolution ETF position peaked at $4.56M in Q2 2021.
  • 218 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2026.

Based on Jaffetilchin Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.